Catalyst Funds Management Pty LTD Jazz Pharmaceuticals PLC Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 600 shares of JAZZ stock, worth $74,238. This represents 0.01% of its overall portfolio holdings.
Number of Shares
600Holding current value
$74,238% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
512Shares Held
57.5MCall Options Held
188KPut Options Held
133K-
Black Rock Inc. New York, NY6.15MShares$760 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$756 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$309 Million0.6% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.1MShares$260 Million0.56% of portfolio
-
State Street Corp Boston, MA1.95MShares$241 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.76B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...